Subtitles section Play video
[ Silence ]
>> OK, so, hopefully that wasn't too painful.
I realize it might have been--
if you even put your name on the piece of paper,
you will get some points that I promise you.
In addition, next time I say that there's something I'd
like you go look up, I hope you take I mores [phonetic]--
you take it seriously.
But don't panic.
Hopefully, that's not too painful.
Let me just tell you very quickly the answers, OK?
So, last time we saw that half life of DNA was
on the order of 220 million years.
And I challenge you to go out and find
out what it-- had to measure it.
And at least one person came to my office hour with the solution
which is to heat the DNA so you can heat it up
and to the high temperature, measure the half life
at the higher temperature and extrapolate back
to the lower temperature.
And you don't have to provide me with a lot of equations
to show that that's true.
But if you just write heat on probably--
number two, I will accept it, OK?
But again, if you have your name on a sheet of paper
with your UCI ID number, we'll give--
you'd get at least some points, OK?
OK. All right, we're back to normal stuff now.
I want to pick up where we left off last time.
We were talking about structure of DNA and reactivity of DNA,
and we saw last time-- oh gees.
What happened here?
One moment.
I just [inaudible] this.
OK, we saw last time a lot about Watson-Crick based-pairing
and structures of DNA.
And it's B-DNA form.
Now, one thing I got asked about immediately
after the lecture was, you know,
ethidium bromide is commonly considered to be a carcinogen.
This molecule over here that we discussed as an interculator
of DNA is also a carcinogen.
It's a molecule that causes cancer and that's the reason why
when we work with it in the laboratory, over here,
we're exceptionally careful to keep it off of our skin, OK?
Now, yeah, it's a-- it articulates into DNA
and DNA interculators can caused,
can help to initiate carcinogesis, can--
it helps initiate cancer in the following ways.
Number one, it distorts the structure of DNA.
I showed you that on the previous slide over here
where I showed you how the structure of the DNA has
to unwind to accept interculator.
So it distorts the structure of DNA.
Number two, it places a hydrophobic functionality
in the center of the DNA.
This hydrophobic functionality can inappropriately attract
transcription factors to the DNA setting off incorrect
transcription, OK?
So those are two possible modes that this can start to cause--
this can start to initiate improper self responses
that will eventually lead to cancer.
And I want to talk about cancer today.
It's one of the prime topics in this class.
It's something we've already spend quite a bit
of time discussing in many different context
and we'll certainly be talking about it
in the context of DNA, OK?
So, any other questions about what we saw last time.
That was a really good question.
OK, last thought about ethidium bromide,
although it is definitely-- it is a cancer causing agent
and it's something you definitely do not want to ingest
or you definitely want to keep it off your hands.
I don't want to exaggerate its carcinogenic potential.
It's also used as an antibiotic in sheep.
I don't know if it's still is, but it was for a while.
It is-- It does have some other--
and so it's actually fed to sheep.
I don't know why sheep.
But in any case, as a tumor forming agent,
its activity is rather modest specially compared
to the other cancer causing small molecules that we're going
to see very shortly, OK?
All right, well let's dive right in this.
So last time, I was showing you that DNA likes
to form Watson-Crick based-pairing.
This is C binding to Gs.
A is binding to Ts and we saw that GCs,
Watson-Crick based-pairings have three hydrogen bonds
and ATs has only have two, OK?
Now, if we know that AT based-pairs are weaker than GCs,
there's a very simple that we can use to estimate the strength
of any two DNA strands taking together.
This rule is called the Wallace Rule and I'd
like you to memorize it, OK.
The Wallace Rule tells us
that the approximate melting temperature
for DNA sequence is equal to 2 times the number
of AT base pairs plus 4 times the number of GC base pairs
in degree C. This melting temperature is where 50 percent
of the DNA is no longer forming a double-stranded structure.
Let me explain.
So0 when you do a UV/Vis scan of DNA, this is what--
here's what you find, OK?
So this is absorbance on the Y axis and wave length,
the nanometers on the X axis.
And this is single-stranded DNA
and then this is double-stranded DNA in blue.
And to get this, you simply add higher temperature.
So at higher temperature, the DNA stands melt apart.
In other words, they separate out into the two single strands
and so at 82 degrees, this is the single-stranded
and 25 degrees, this is the double-stranded DNA.
Notice that the absorbance at 260 nanometers is higher
for the single-stranded DNA than the double-stranded DNA.
So you can use that change in absorbance to follow whether
or not your DNA is single-stranded
versus double-stranded.
And so, you can do this while at the same time,
you ramp up the temperature and at
about 50 percent-- and so here it is.
Pure double-stranded DNA, lower absorbance and then here it is
at a higher temperature
where it's entirely single-stranded DNA.
And the approximate 50 percent part
where 50 percent is melted is called the melting temperature.
And again, you can estimate what this melting temperature is
using this Wallace rule formula.
People in chemical biology laboratories uses Wallace rule
formula on a daily basis, OK, certainly in my laboratory
and certainly and probably five
or six other laboratories here at UCI Irvine.
So, I'd like you to memorize this rule.
It's incredibly useful.
Now, you're probably wondering, big deal.
So I know whether or not something melts, whether
or not it forms double stranded DNA.
If you know the temperatures
that it forms double-stranded DNA, you can start
to design structures made out of DNA.
Let me show you.
OK. So here are structures of DNA where it's single-strands
of DNA that are now hybridizing against each other
and forming elaborate patterns such as this pattern here.
And here's an atomic force microscope image
of this double-stranded DNA and you could see it's all--
it's forming this exact costly pattern
that was designed using something just a little bit more
complicated than the Wallace rule
which I asked you to memorize, OK?
It gets even better.
Check this out.
OK. So this is worked done by Paul Rothemund and colleagues
and coworkers at Caltech.
And he's using the Wallace rule to design DNA that folds
up into happy faces over here or check out this map
of the world written out of DNA that's been folded
up with itself.
OK. So that Wallace rule that I asked you
to memorize is actually pretty powerful.
You can develop whole structures of that stuff.
Now, exactly what the structures of DNA are going to be useful
for is not a hundred percent known at this point.
There are sort of a frontier
in chemical biology building structures out of DNA
and then trying to do something useful with them.
I've only seen one paper in 20 years of staring
at these beautiful pictures that has convinced me
that maybe there might be something useful about this.
And in that paper this DNA-- a DNA structure like this one,
not the happy face but something elaborate was used
as a delivery vehicle that bound to the surface of cells
and then dislodged drug therapeutic.
And it's possible that our future might feature many more
of these sort of examples of nanometer scale structures
that are designed by you, by the people on this room
to have specific properties such as binding
to specific cell types, unloading cargos
at specific times, et cetera.
This is a really exciting frontier and I encourage you
to think about it in your proposal preparation
because it's an area that's kind of wide open
for creative-- for creativity.
OK, so in addition to those sort of macro structures of DNA
that we saw, short stretches of DNA can also fold
and there's a couple of canonical structures
that we're going to see time and again.
One of these for example is called-- are called hairpins.
One of these is called the hairpin.
And so, these consist of a sequence
that folds back on itself.
Notice that it satisfies all
of the Watson-Crick base pairing requirements, G is to Cs.
A is to Ts and it forms something that looks kind
of like an old-fashioned hairpin.
OK. And it looks structurally like this.
This is the x-ray crystal structure of what it looks like.
And again, we're going to see this quite a bit.
OK. So DNA has a propensity to fold on itself.
It wants to form Watson-Crick base pairs.
It wants to form Watson-Crick base pairs with other sequences.
It wants to form base pairs with itself.
And so for this reason, DNA is rarely found.
It's sort of an unwound
which rarely found a single-stranded DNA
for one thing.
And furthermore, it's rarely found in the sort
of canonical B-DNA conformation that I've been showing you
where it says nice right-handed coiled double helix.
Rather, in cells, we typically find DNA in a wound
up configuration called a supercoil.
So a supercoil is where you take a coil
such as this old-fashioned telephone cord
which I'm sure is unfamiliar to everyone in this room.
But back in my day kids, we used to have this
and it would form the sort of supercoils
and it drove you nuts.
You know, you constantly be on the phone trying
to untangle the darn thing.
In fact, she [phonetic] was kind of a nice thing to do
because if you're on the phone with the tense conversation
or something, it gave you a task to take your mind off
of the annoyances that you're dealing with on the phone.
But anyway, so this is called supercoiling
and this is an example of a DNA plasmid which is a sequence
of DNA that forms a circle.
OK. So this is a nice plasmid DNA and again we rarely find it
in this sort of B-DNA where it's completely unwounded
configuration, rather it likes to twist up.
So here's a little twistiness.
Here's more twistiness, even more twistiness
and then finally even-- the most twistiness.
OK. So that's really the structures of DNA that we find.
For short sequences, we find it wound
up with itself to form hairpins.
I showed you that structure first.
For larger sequences like plasmids,
we find it supercoiling and twisting itself up.
And then for even larger sequences like you carry
out at genomes which I'll show you on the next slide,
it gets even more twisty than that.
OK. So-- oh, before I get to that,
here's why it has to get so twisty.
This is one of the benefits of having it coiling up on itself.
This is just the DNA in a single E. coli cell.
This is a classic picture of that DNA
where really toward [phonetic] the force microscopy was used
to lice the cell and spew out all of its DNA
and you could see it's just an enormous amount of DNA
for such a small cell.
And the human cells face a similar compaction problem,
right.
The human genome would be a rough--
roughly 1.7 meters if completely unwound.
So this property to want to wind on itself,
to coil up with itself is actually a really important one.
And so, when we look at human DNA,
we find that it's compacted up into chromosomes.
I'm sure-- hopefully, this is not an unfamiliar concept.
In fact actually, I showed you examples of chromosomes
from I believe it was guinea pigs when we talked
about bromouracil earlier this week.
In any case, so here're some images
of human chromosomes over here.
And here's how it's compacted up.
So, the DNA, here's the B-DNA
that we've been looking at over here.
I admit this is a terrible rendering because it looks
like it's a single helix.
Note that it's lacking the major groove.
This is-- or the lacking the minor groove.
This is one of my pet peeves
about artistic depictions of DNA.
But I'm going to let it slide by at this moment.
In any case, so here's the regular B-DNA.
The B-DNA is going to wrap
around the protein structure called the histone
and this is going to act like the spools for thread.
And then these histones are going to coil up
and those coils are going to coil up further
until eventually you get
to something that's massively compacted into a chromosome.
Now, the problem of course and this is the problem
if you're on the phone as well.
So imagine you're on the phone
with these old-fashioned telephone cords,
what you find is it has very hard to untangle the DNA
without disconnecting the cord and making a little break in it.
OK. And that's one of the annoying things
about supercoiling of old-fashioned telephone cords.
Similarly with DNA, where you have this one 1.7 meter long
object and a 20 microne long cell, there has to be a solution
to uncoil the DNA and the solution is
to make transient breaks.
So shortly breaks in the DNA using an enzyme called
DNA gyrase.
And here's an example of this.
This is a DNA gyrase that acts kind of like scissors, OK?
So, notice that it's a dimer.
The two arms down here can open up and the thing could just grab
onto the DNA and then introduce two breaks
on the DNA allow the super-- the DNA to relax, to uncoil
and then it gets rejoined.
This turns out to be a Achilles' heel
for bacterial cells, for cells in general.
In other words, it's a spot that can be targeted
with the antibiotics and we'll be talking about this.
We'll be talking quite a bit about different ways
that antibiotics works.
So antibiotics are pharmaceuticals, therapeutics
that are given to patients
to eliminate bacterial infections or fungal infections.
In this case, this is a really effective antibiotic that's
giving quite a bit.
This is the antibiotic Cipro which I'm sure many of you
in this classroom have taken at one point.
I read somewhere that like 85 percent of American women come
down with a UTI, a urinary tract infection at some point,
the first line of antibiotic used
against that is often Cipro.
And Cipro works by inhibiting the DNA gyrase of bacteria.
OK. Here's another one as well, another inhibitor as well.
OK, so let's talk a little bit more
about these bacterial plasmids because I want to transition
into a discussion of biotechnology and cutting
and pasting DNA in large scale.
So, oftentimes,
DNA is transferred amongst organisms using plasmids.
Plasmids are short circular stretches of DNA.
They need to have-- all plasmids need to have two properties, OK?
They must have sequences that encode two items.
Item number one is an origin of replication.
The origin of replication abbreviated ORI is the spot
that somehow convinces the cell that's taking up the plasmid
to start transcribe-- or start replicating that DNA, OK.
So that origin of replication kicks off replication
of the plasmid.
Without that, the plasmid would just be there
and it wouldn't get copied, and it wouldn't get passed
on to the next little guy, OK?
So that's absolutely essential.
The other essential thing is that the plasmid has
to confer some advantage onto the new host, OK?
In other words, the new bacteria has to take it
up and say, "Oh, yeah.
This is useful."
Otherwise, the plasmid will get quickly shunted aside
because cells are under a lot of pressure.
They have a lot of works to do and they have a limited amount
of resources, carbon, nitrogen, oxygen, things like that
that are available to do all of the priorities that they have.
OK, and that's kind of a long winded way to say that this has
to confer some resistance oftentimes
to some sort of antibiotic, OK?
So, resistance markers are sequences of DNA
that encode a protein that confers resistance.
OK. So for example, you can have a resistance marker
that encodes resistance to the antibiotic tetracycline
and this gene will work
by actively pumping tetracycline out of the cell, OK?
So, when the-- when the cell takes up this plasmid,
it's going to synthesize this pump that goes to the surface
of the cell and then every time it gets tetracycline it just
pumps it out of the cell furiously
and that allows the cell to live.
So only the cells that have the plasmid will survive an
onslaught of the antibiotic tetracycline
which again is a very common antibiotic
that I mentioned a few of you have encountered.
It's often used, for example, I believe for acne treatment.
OK. Here are some other classic examples of other antibiotics
that are used in my laboratory
and other chemical biology laboratories
as selection markers for drug resistance.
And the way this works is will coat the cells,
the bacterial cells on a plate and the plate has an agar
which I'll show you the structure very shortly.
It's isolated from seaweed.
It's a basically just a polymer and inside this agar plate,
we'll have some concentration of one to these antibiotics.
And so the only colonies and each one
of these circles is a colony that appears
on this plate are colony or bacteria cells that have taken
up the plasmid because now,
those cells are resistant to the antibiotic.
OK, so here is another way that this can work.
So, antibiotic that's commonly used is chloramphenicol.
Chloramphenicol inhibits the ribosome.
We talked about the ribosome before.
The drug resistance gene encodes an enzyme called chloramphenicol
acetyltransferase or CAT
and this enzyme transfers an acetyl group
to a primary hydroxyl of chloramphenicol, OK?
So, here's the acetyl group and acetyl-CoA and it's going
to get transferred to this primary hydroxyl in a reaction
that essentially disarms the chloramphenicol preventing it
from binding to the ribosome and allowing the cells on this plate
of chloramphenicol to live.
Third, a very common resistant marker, OK,
so I've shown you tetracycline.
We've talked about chloramphenicol.
Third one, the third one are beta-lactam antibiotics
of these sort.
Notice that this is a beta-lactam.
A lactam, of course, is a cyclic ring that has an amid bond
on it, and this is beta because it has two carbons, alpha, beta.
And so, that's the beta-lac--
that's the origin of the beta lactam nomenclature
which I know we talked about in 51C.
Hopefully, you encountered as well.
In any case, beta-lactamase is a--
enzyme encoded by the beta-lactamase gene
that confers the ability
to hydrolyze this amid bond that's part
of the beta-lactam ring.
And this is a very common gene that's found out on environment.
So, you can probably scoop up, you know,
some dirt over here just outside Rowland Hall
and you can readily find this beta-lactamase gene.
And so for this reason,
medicinal chemists are constantly making new
antibiotics that avoid that environmental drug resistant
that sort of omnipresent, OK.
So for example, here are two different kinds
of beta-lactam based antibiotics
and notice the structural differences.
This one has this benzoyl functionality over here.
This one has a carboxylate--
carboxylic acid and a phenol group instead.
And so, all of those little differences change,
affect the ability of the drug resistance enzyme,
the enzyme conferring drug resistance to bind
to the antibiotic and hydrolyzes them and bond.
Maybe this carboxylate sticks into the protein
and prevents the binding and that's a useful thing.
OK. So we're constantly on the hunt for new antibiotics
because the antibiotics we have seem to allow very rapid risk--
evolution of drug resistance and so,
there's a constant need really for our society
to develop new classes of antibiotics
that are more effective than the previous generation.
And in the last 10 years or so, there's been a real renaissance
of research in this area
to develop even more effective antibiotics.
OK. Let's get back to our discussion of DNA structure.
I showed you structure of plasmids.
Here's structure of a eukaryotic genes,
eukaryotic DNA that's wrapped around nucleosome, et cetera.
I don't have very much more to say about that.
Let's take a closer look however
at the structure of these histones.
So, the histones are these hexameric proteins shown here
in yellow and green where in green,
these are positively charged residues, OK?
So those are residues whose positive charge can interact
with negatively charged phosphodiester backbone
of the DNA.
Charge-charge interaction.
Nice long range interaction.
This wrapping up though basically hides the DNA
and prevents it from being transcribed.
When it's wrapped up around the histone it can't be a read
out and, you know, use for transcription.
And so, basically, whether or not the histone is wrapping
up things, it's-- it controls transcription
and controls packaging.
So these proteins over here are very tightly regulated
as to whether or not they're going to be binding to the DNA
and one easy way to do this regulation is
to acetylate the lysines side chains, OK, and I'll show you
that on the next slide.
OK. So first, this is the structure of lysine.
Lysine has a primary mean
and here's lysine within acetyl group.
What do you think the charge is if something has a primary mean
at neutral pH which is the pH roughly
of the cell approximately?
So it has a primary mean functionality
in neutral pH. What is its charge?
[ Pause ]
I'm a very patient guy.
[ Laughter ]
>> Positive one.
>> Positive.
>> Positive.
Positives.
Very good.
OK, good. So, when-- So if this is bear lysine,
it will have a positive charge and acetyl group over here,
it is back to neutral, OK?
So this guy, positive charge, acetyl group, neutral.
So that controls whether or not that lysine, the amino acid
of the protein interacts with the DNA.
If it's positive charge,
it's like a homing beacon for DNA, right?
The DNA is negatively charged.
Two of these want to stick together.
If it's acetylated however, it's not going--
it's going to be neutral and the two are not going to want
to interact with each other.
Here's one that's even wilder.
In this case, you're taking the primary amine
of lysine side chain and turning it into a secondary amine
or tertiary amine or even a quaternary amine.
And when you do this,
you're making the lysine side chain fixed
as a positive charged.
OK, now I should say, it's not fixed permanently.
It used to be thought that it is but now we know
that actually this is a reversible modification
as this is acetylation, OK?
So, this case, it's binding to DNA, binding to DNA and then
when you get rid of these methyl groups, it's back to--
it's still bonded to DNA but then it can get acetylated
so it's no longer binding to DNA.
OK. So there is a whole series of different modifications
to the surface side chains, the surfaces of the histones.
And all of these modifications have an important consequences,
OK.
So for example, some of these modifications
like these larger ones down here direct the histones
into the proteosome which is basically the garbage disposal
for the cell and so those get flushed away
and thrown into the trash.
And then others like this phosphorylation
of a hydroxyl functionality found on the surface
of the DNA can regulate the structure of the histone as well
and perhaps interfere with this binding
to the negatively charged DNA.
OK. So, all of this stuff is tightly choreographed,
there are enzymes that add each one
of these modifications highlighted
in blue on the slide.
And those enzymes are going to control its binding affinity
for DNA and in turn control whether or not the DNA is hidden
or available for transcription.
And you can imagine, this is very tightly choreographed
by the cell.
If anything gets in there to mess stuff up,
all kinds of havoc can be wreck, right?
Because the cell has to control, you know, turning on, you know,
specific genes has specific times, right.
You would not want, for example, you know, a muscle cell
to suddenly start growing, I don't know, neurons or some--
you know, the genes that are required for neuron growth,
neurite growth or something like that.
That would be really bad, OK?
So everything is very tightly choreographed at this level.
All right.
There are of course small molecules
that inhibit these histone deacetylases.
I shouldn't say of course.
This is actually a discovery that was made
by Jack Toden [assumed spelling] who is a graduate student--
when I was a graduate student, the same lab where I was.
This discovery is made when I was a graduate student
in the laboratory where I was getting that Ph.D. And in short,
this is what the-- an acetyl lysine surface looks
like of the histone.
So here it is.
Taking out here is an acetyl and then here's trapoxin
which looks remarkably like this lysine,
this acetyl lysine, right?
This look very, very similar.
Maybe a slightly different number of carbons
but it looks very, very similar.
And so, this is going to be a one possible way
to design inhibitors of enzymes which is
to mimic the substrates, OK?
So this is the starting material for the histone deacetylases,
the enzyme that chops off this acetyl group.
And then this compound over here is going
to inhibit that deacetylation.
There's more written about this in the book.
But in any case, this two look very similar and so,
that substrate mimicry, that mimicry
of the starting material is a very common way
to inhibit enzymes.
It works really well.
We're going to see that time and again throughout this class.
OK, I went to change gears now.
I've shown you all the cool things
that you can build out of DNA.
I want to talk to you next about how
to actually synthesize the DNA so you can build these things.
OK. If you want to make happy faces or maybe you want
to make the first frowny [phonetic] faces
out of DNA hasn't been done before to my knowledge.
You're going to have to know how to synthesize the DNA
so that you can make that happen.
OK, so I'll first-- I'll talk very briefly about DNA synthesis
in the lab but first I want to talk to you about DNA synthesis
by the enzyme DNA polymerase.
OK, so DNA polymerase takes a single-stranded piece
of DNA called the template and adds a second strand
of DNA to that template.
OK. Now, all DNA polymerase that's found
on the planet have a common mechanism.
And they all require a starting primer strand that gets the--
that gives it sort of a running start.
Without this running start, the enzyme doesn't know
where to begin and this is actually a very useful property,
right?
You don't wan DNA polymerase to come along
and start synthesizing random, you know, bits of pieces
of DNA here and there.
And it turns out that this is one that's been exploited quite
a bit.
And I'll show you some examples of that in a moment.
OK, so this starter is called a primer, the starting--
it forms again, double-stranded DNA with the targeted template
and then DNA polymerase lengthens this priming strand
in a five prime to three prime direction.
In other words, it grabs onto these three prime.
It adds the new five prime, et cetera, OK?
So this direction here is also common to all forms
of DNA polymerase found on the planet,
five prime to three prime.
The starting materials here are nucleotide triphosphates
structures-- so it's a nucleotides
that I showed you earlier
but with triphosphates attached to them.
OK. And basically what its doing is again it's taking the green
primer strand and lengthening it as shown
by this arrow over here.
So this is a classic experiment that was done
that applied this principle to crack the genetic code.
The genetic code is the code by which sequences
of DNA spell out amino acids, OK?
And this was back in the 50s and early 60s.
There's this enormous mystery about what
that code actually was.
OK. It was like this, you know, unsolved major, major problem
and Marshall Nirenberg-- I think it's Rockefeller.
I might be wrong about that.
All right.
Marshall Nirenberg used this property
to crack the genetic code.
What he did was he synthesized templates that were long strings
of particular DNA sequences, OK?
So he made a long string of As for example and then he looked
at not what was synthesized by DNA polymerase
but downstream what was made by ribosomes
when you give them a long string of As.
And then by doing that, he could figure
out what the genetic code was.
OK. So again, DNA polymerase requires a template
to lengthen the existing strand.
Only RNA polymerase can start from scratch, OK?
So RNA polymerase is kind of an exception to this rule.
DNA polymerase requires a priming strand reverse
transcriptase which takes RNA and synthesizes DNA,
we saw that earlier also requires a primer
and deoxynucleotide triphosphates.
RNA polymerase is kind of a special case.
By the way, any questions?
You guys feel free to interrupt
if there's anything that comes up, OK?
Anything that's unclear, you want to know more information
about it, don't hesitate to stop me, OK?
Yeah.
>> Does the primer get replicated as well or is it--
>> The primer gets extended but it doesn't get replicated
in the load that I'm showing you.
When we talk about PCR,
we'll show that it actually can get replicated, so, OK.
That was a good question.
Other questions?
Yeah.
>> If you wanted to hybridize [phonetic]
like a piece of a primer--
>> Yeah.
>> Lamination [phonetic] in it--
>> Yeah.
>> How many like base pairs do you usually need to--
>> OK, these are great questions.
OK. Awesome.
I'm glad you're asking.
I forgot to ask your names.
What was your name?
>> Paul [assumed spelling].
>> Paul and?
>> Anthony [assumed spelling].
>> Anthony.
OK. So Anthony's question is how many base pairs
of DNA should you have to get the--
to use as the primer to get DNA polymerase going.
OK. And it kind of depends, OK?
So, you want DNA polymerase to pick
up a specific gene and/or a specific sequence of DNA
within a complex mixture.
And so, if you want to pick up a specific gene
in the human genome, you need a primer that's
at least 18 base pairs in length.
OK, that's kind of a magic number.
OK? So, 18 base pairs means that you're uniquely encoding one
and only one gene in the human genome, OK?
Thanks for asking.
It's a good question.
On the other hand, if you want to do this at, you know,
a lower temperature, you can use the Wallace rule and get away
with maybe a shorter sequence.
OK, maybe you don't need such specificity.
Maybe your mixed-- your starting population is less complex.
OK? Thanks for asking Anthony and Paul.
OK. Let's move on.
OK, so here's a close up view of what I've been telling you
about in hand waving examples.
We're now zooming down to the level of atoms and bonds that,
of course, is what really thrills me.
So, here is the primer and DNA polymerase, not shown inside,
of course, this primer is forming a double-stranded DNA
to the template strand and also not shown is
that the template strand must have adenine.
Over here, the hybridized to the sliming [phonetic], OK?
In any case, the starting material used here is a
deoxynucleoside triphosphate.
Note that deoxy at the two prime hydroxyl.
OK. And here is the two prime-- or sorry.
Here is the triphosphate functionality.
The living group in this reaction is going
to be diphosphate which is use very commonly
in biology as a living group.
This is nature's tosylate or mesylate that you learned
about back in Chem-51C.
This thing works really well as a living group and it's one
of the reasons why we're going
to see it quite a bit as a living group.
The-- All DNA primaries, all enzymes that use diphosphate
as a living group absolutely require a dication to bind
to this diphosphate and their requirement is
for magnesium in DNA polymerase.
OK? So, actually a very common problem that I see
in my own libratory when a newbie shows up in the lab
and they have trouble with their DNA polymerase,
nine times out of 10 it's due the low concentrations
of magnesium.
OK? And there's a lot of ways
to get low concentrations of magnesium.
So, a little tip.
OK, so here's magnesium.
What is it doing?
Magnesium is a Lewis acid that's chelating to this diphosphate
and stabilizing its negative charge.
Doing this makes it a better living group, right?
This means that if it goes out into the solution,
it doesn't require some massive rearrangement of water,
it's already been stabilized.
It's at lower potential energy then it would otherwise be.
OK, so here's the role of DNA polymerase.
And I'll show you instructionally what it looks
like it a moment.
DNA polymerase brings together the three prime hydroxyl
of the priming-- the primer together
with this incoming nucleotide triphosphate and then sets
up a nucleophilic attack on the phosphorus
of the nucleotide triphosphate.
Note too that there is a second magnesium ion
in the active site.
This second magnesium ion does two things.
Number one, it helps to stabilize the alkoxide formed
when this three prime hydroxyl is deprotonated, OK?
So notice that it's forming an ion pair relationship
with this alkoxide.
Number two, it actually increases the nucleophilicity
of the lone pair that's going
to this nucleophilic attack over here.
OK, so what magnesium is doing here is it's making available--
better available this long pair for an attack
by helping promote the deprotonation of that hydroxide.
If the hydroxide is deprotonated,
there's more long pair that's available for the attack, right?
Make sense?
OK. This forms an intermediate.
There's a clasp [phonetic] of intermediate and not only gets
to what we saw on Tuesday when we looked at the hydrolysis
of DNA, exacts in mechanism.
That intermediate is depicted.
I'm showing arrows over here.
But again, we've looked at that intermediate before
so I fell comfortable living it off at this slide.
OK, any questions about this mechanism?
Yeah.
>> Where does the magnesium come from?
>> Great question, what is your name?
>> Nick [assumed spelling].
>> Nick, OK.
Nick's question is where does the magnesium come from?
Magnesium comes from the food you eat.
It comes from, you know, you added to the test tube.
So, typically we'll add magnesium chloride
or magnesium sulfate directly to the eppendorf tube.
Then you'll test tube that we use for these reactions, OK?
But in humans reading, you know all kinds
of food as magnesium in it.
OK. So, but it's absolutely essential, OK?
So without the magnesium this reaction does not go, OK.
It makes sense because I'm showing you what a key role
it place.
OK, let's look structurally at what this actually looks like?
This is an enzyme that again has a number
of different orthologs or homologs.
These are enzymes that do more or less the same thing.
Reverse transcriptase synthesizes DNA
from an RNA template.
The enzyme Taq is a DNA polymerase that's use quite a
bit in research for a tool called PCR,
which I'll talk about in a moment.
But all of these enzymes have a right handed structure, OK.
And here's what the structure looks like.
OK, so here's a right hand over here.
Here's my right hand.
And it's grabbing on to the DNA, OK?
So the DNA is in red and orange over here
and here is the enzyme grabbing onto this DNA.
Now what happens is during the synthesis, the DNA treads itself
through the crack form by my thumb and palm, OK?
And as at a certain-- when the crack nucleotide triphosphate
binds to the priming strand, the newly synthesize strand,
the enzyme can then close.
When it closes, the palm and the thumb get closer to each other,
palm, thumb and fingers.
OK. So it closes a little bit like this.
Each time that closes, that brings the magnesium's
up to the triphosphate setting up formation
of the covalent bond that I showed
on the previous slide, OK?
So each time the hand closes,
that's one nucleotide that's been out.
OK, so let's do this, right.
We have this one bond.
OK, now let's do a couple more, bond, bond, bond, OK?
Now here's the deal.
This enzyme is really cranking.
It's actually going to do a thousand up to a thousand
of this per second for some of these enzymes, OK.
So that's like, you know, too fast for it to see really.
OK. So this enzyme can really turn over very quickly
and actually this is actually something
that my libratory is directly observed.
We actually have watched one of this enzyme cranking over
and we've watch differences
as we add difference substrates to the enzyme.
It's really absolutely fascinating series
of experiments.
OK, so, all of these enzymes use a common mechanism.
Again, the enzyme doesn't close
until it gets the crack nucleotide triphosphate
that binds to it at that point it closes.
So in fact actually the rate determining step
for this enzyme is actually the rival
of the cracked nucleotide triphosphate.
A is to Ts or DATP to Ts, DCTP to Gs, et cetera.
OK, I'm going to tell you a little bit more about why I'm
such in love with this enzyme.
This is a 3D machine.
I like fast cars and I like fast enzymes.
This one is really amazing.
So check this out.
Imagine that double-stranded DNA was about a meter or so
in diameter, OK, running a long the length of this room, OK?
So we've got some DNA running through the room, all right.
If that was true, DNA polymerase would be about the size
of the FedEx delivery track.
OK. Including the polymerase
so there's some other replication machinery
that I'm living off for now that's involve as well.
But it would be the roughly the size
of FedEx delivery track pulling up right here, OK?
But here's the thing.
This delivery track would be racing along
at about 375 miles per hour.
And that's how fast DNA polymerase is going
in scale to the DNA.
Furthermore, it's making about a thousand covalent bonds per
second which is insanely, insanely fast.
And in addition, I haven't talk about this yet
but there are other subunits of DNA polymerase
that are providing an error checking
and a correction function such that the enzyme is making
to scale one error every a hundred or six miles or so, hey,
which is extraordinary, OK, 375 miles and hour
and one error every 106 miles.
OK, this is truly remarkable stuff.
You could read more in this reference down here.
OK, now, because this enzyme is so efficient
and so superbly specific
at getting the right Watson-Crick base pairing,
this has been used very commonly in lots and lots
of laboratories, chem-bio labs, molecular bio lab,
biochemistry labs, forensic laboratories,
all kinds of labs used DNA polymerase and they often use it
to amplify up copies of the DNA using a technique called the
polymerase chain reaction invented
by Kary Mullis [assumed spelling] amongst others.
The way this works is you start with some target sequence
of DNA shown here in purple.
Again, we'll call the target B template, OK?
So that's the template DNA that you're going to amplify.
Now, there are going to be three steps to this PCR reaction.
In step one, we hit the DNA
up to high temperature say 95 degrees.
And as we've discussed earlier today, DNA when it's heated
up the high temperature goes
from double-stranded to single-stranded.
It falls apart.
In step two, the solution is cool down
and that allows the primers shown here in green and blue
to a [inaudible], in other words hybridized
to the single-stranded DNA.
Note that these two purple strands don't find each other.
The concentration of template if very, very low.
In fact, you can get down to just a few copies of DNA.
So they never find each other.
They are like, you know, lost from each other
after the heating step.
But you have a high concentration of this green
and blue primers that can grab on to the crack sequence of DNA.
That motion targets DNA polymerase, drags DNA polymerase
to synthesize a specific stretch of DNA.
And then that's done in the third step
when the primers are extended using again DNA polymerase,
DNTPs, magnesium chloride and a temperature of 72 degrees.
To make this work, we use a special DNA polymerase
that likes to run at 72 degrees.
It's a type of polymerase called taq which is found in hot fence,
hot springs and it's in an organism that's found
in this hot springs that has evolved
to operate at this temperature.
And so, at 72 degrees, the enzyme starts cranking.
At the lower temperature, it's not working.
At the higher temperature, it stops working.
But in 72 degrees, it's loving [phonetic] life.
Again this is Celsius.
This is pretty warm, and its start synthesizing this black
strand of DNA.
If you do this process a whole bunch of times, each cycle,
you get a doubling of the amount of DNA
and so you do this 30 times.
You get a huge amplification for some target template of DNA.
Some target sequence of DNA.
OK. Makes sense?
Any questions about this?
I'm hoping I'm not telling you anything you don't already know.
PCR is now taught like high school and stuff like that now.
So, OK, summary.
Right hand role, we looked at species
about the magnesium two plus, stabilizing the nucleophile.
We've looked at this already.
Why don't we move on?
OK, so DNA polymerase is also a terrific target for inhibitors
and reverse transcriptase inhibitors have been very,
very important compounds for stopping synthesis of DNA.
There're many reasons why you'd want
to stop the synthesis of DNA.
To treat, for example cancer,
where cells are dividing uncontrollably
if you can shutdown the replication of DNA,
you have an effective way of stopping cancer.
And in fact actually, childhood leukemia's were stopped
in their tracks back in the late 70s
through the wonderful research of one
of my scientific heroes the great Gertrude Elion shown here.
Gertrude Elion was born in 1918.
Her parents wanted her to become a nurse, OK?
So they send her to college and they said,
"Go and become a nurse."
She actually wanted to become a chemist,
and when World War II broke out,
she was given her opportunity, OK?
So during World War II, the man were sent to the front to fight
and there are a lot of opportunities
that were available to women that weren't available before
that and she's one of those people
who took that opportunity.
She joined Burroughs-Welcome where she worked
with George Hitchings for her entire career.
She's one of this people
who spend her entire career at a single company.
And together with George Hitchings,
she discovered this class of compounds
that inhibits DNA polymerase and ended
up after having a major impact on childhood leukemia.
She is, you know, she is a true superstar of science.
OK, one last thought.
Gertrude Elion never received her Ph.D. She went
on to receive a Nobel Prize in the 80s for this work.
She did it through sheer force of will,
through her determination to contribute something.
And I highly, highly recommend in interview of her
and I'll leave and put it up on the board over here.
There's-- If you want to learn more about her,
this is terrific interview of her that's
in the documentary that I recommend.
OK, so the documentary is called Isaac--
can you see this OK, normally?
OK. "Isaac-Newton and Me"
and the director is the great Michael Apted.
I could actually have a whole class just
on Michael Apted's documentaries.
But in any case, she's interviewed in this documentary
and she talks about the incredible pride
and just the joy that she felt
when she would visit children's hospitals
and she would see kids being treated for the first time
with her compounds, and how transformative that was
in the life of these kids.
These are kids that were, you know, slated to diet
at very young age, just like the ages of 10 and 12
and that were suddenly getting cured by these compounds.
OK, let's take a closer look
and understand how these compounds work.
OK, so she invented a series of inhibitors of DNA polymerase
that look like this, OK?
So this is one called AZT.
It's also used very as a--
anti-HIV compound because it inhibits reverse transcriptase.
It looks kind of like a DNA base.
It has a deoxy at the 2' prime hydroxyl but in place
of the 3' prime hydroxyl, there is an azide, OK.
So what happens is this gets taken up and phosphorylated
to give a triphosphate and then DNA polymerase attempts
to use it as a substrate.
But what ends up happening is instead of a 3' prime hydroxyl,
there's an azide here and the azide caps the synthesis
of the new strand of DNA preventing it
from being lengthened, OK.
So similarly, this is a ddC another compound that's used
in the treatment of HIV and also leukemia and instead
of a 3' prime hydroxyl, it has a hydrogen there.
And so again, it gets used by DNA polymerase
and the polymerase can no longer lengthen the nascent strand
of DNA, OK, so both of these shutdown DNA syntheses.
I'm simplifying things a little bit.
There is another class compound, non-nucleoside analogs.
These are nucleoside analogs that are also used against HIV.
But that kind of gives you a taste
for what Gertrude Elion did.
She had a major, major impact in the fight against viruses
and in the fight against leukemia.
And I actually had the pleasure of meeting her once in life.
The day I was getting my Ph.D. at my graduation,
she was receiving an honorary Ph.D. from Harvard
and I just shook her hand.
That's about it.
I didn't have any profound conversation with her
which is to my regret.
But a truly remarkable woman, a true superstar of science.
I can not say enough about her.
I can have a whole lecture about her.
Why don't we move on?
OK, so, that's DNA synthesis in the cell--
oh, question over here.
Yeah.
>> So these nucleotides that she synthesized,
how did they deliver [inaudible] cancers cell--
>> Oh, this is such a good question
and I'm so glad you asked.
What is your name?
>> Bobbin [assumed spelling].
>> Bobbin?
>> Yes.
>> OK. So, Bobbin's question is how do you get the compounds
to the cancer cell.
What we're going to see time and again is
that cancer cells are actively eating up every little bit
of nutrient that they could find.
They will just be devouring stuff that's around them.
And so for this reason, they
and other dividing cells will more preferentially take
up drugs like these that are fed to the patient
that are injected into the patient.
OK. So, the problem of course is that there are other cells
in the body that are also dividing
and that will unfortunately take up this chemotherapeutics
and also end up dying because their DNA synthesis will
be impaired.
So, OK. Great question.
Thanks for asking.
OK. So, I want to-- I don't have very much to say
about chemical DNA synthesis.
I think it's an obviously amazing topic.
This is one of those areas of organic chemistry
that is a true triumph.
OK, so, we're going from strength to strength today.
In DNA synthesis in the laboratory has been so optimized
that we're at the point where we get 99.9 percent yields
for reactions, OK?
This is really the ultimate goal in the quest
to do organic synthesis.
And it was set in line by the great Gobind Khorana
who won a Nobel Prize but also Bob Letsinger
and Marvin Carruthers.
These guys deserve a Nobel Prize
because this really did kick off a revolution in biotechnology
that was made possible by the synthesis of DNA to make primers
which in turn allows PCR, which in turn allows smiley faces
out of DNA and all those other great discoveries
that we've been talking about.
OK. Now, I just want you to scan this topic in the book.
Don't get too worked up about it.
In the end, we have these machines that looked like this
where you have a bunch of bottles down here
that inject-- that you can use.
You could program a computer up here to open--
to inject reagents directly into a flow cells
that have the DNA sequence that you're trying to synthesize.
So you do this using solid support base synthesis
where did-- the nascent strand of DNA is be--
is attached to some sort or bead and you basically flow
in the reagents one after another
and couple the correct nucleotide directly
onto the DNA sequence.
It's a little more complicated than that
but here's what you need to know.
If you want to synthesize any sequence
of DNA that's 150 base pairs, 150 bases or less,
you get on the web and you call up someone probably in Texas
or somewhere like that.
And there will be a whole warehouse of machines like this
and you enter into some form on this--
on their website exactly the sequence of DNA that you want.
And that sequence will get ported to a machine that looks
like this and there'll be this warehouse just filled
with these machines.
And then there's a bunch of technicians on roller blades
that are going to be running around
and keeping the machines fed with reagents.
You won't see any of this because at the end,
you'll get a FedEx package
with your DNA sequence probably in a couple of days.
Some of these I think are even overnight, right?
So overnight, you're going to get your sequence
of DNA perfectly cleaned up, purified, delivered to you
at 95 percent or 99 percent purity depending
on how much you decide to pay for it.
And, you know, it will be perfect every time.
You won't even have to think about the chemistry.
I love that.
That's the goal of organic synthesis.
The goal of organic synthesis to make this totally turn key
so that we can then use this thing
to answer biological problems
which is what I want to you about next.
OK, here's one example of using this, an amazing ability
to do DNA synthesis to address biological problems.
You can print sequences of DNA on microscope slides.
OK. So here's a machine that's nothing more fancy than I think
in this case it's an ink jet printing device.
OK. And it's going to be printing
out little oligonucleotide one after another
on this identical microscope slides.
So each square down here is a microscope slide, OK.
And across the surface of these microscope slides,
we're going to have a bunch of different sequences of DNA
that have been printed down onto specific spots, OK.
So what this is going to do is this is going
to give us an array of different sequences
of DNA each one capable
of hybridizing forming Watson-Crick base pairing
to a different other sequence of DNA or RNA.
OK. This is a technique called the DNA microarray.
OK. So, here's the way this works.
Let me just show you what it looks like, OK?
So now I'm zooming in on the microscope slide.
OK. So here's what it looks like.
Each spot over here is a different sequence of DNA
as you set up the hybridization such that you end
up with a fluorescently labeled sequence, OK.
So each-- again, each spot has a different sequence of DNA.
If there is a complimentary sequence in your sample,
then you will see fluorescence, OK?
So, in green, that tells you
that your sample has this particular sequence.
OK. And it's known exactly what the sequence is in green that's
down there, OK, because you've synthesized the compliment
to put it down right there.
OK, so-- I don't know.
Let's just say this is the gene that confers resistance
to beta-lactam antibiotics.
Yes, you have that gene because you're seeing green spots
right here.
In practice, this can be made a lot more complicated, OK?
Let's imagine now that we have two samples, one that we label
with red sequences and one that we label with green sequences.
OK. This allows us to compare all
of the different DNA sequences present
or RNA sequences present comparing them
against red versus green, OK?
And let's take a closer look.
OK, so each oligonucleotide hybridizes
to a different mRNA transcript where the one sample is labeled
in green and the second sample is labeled in red.
OK, here is the way this works.
On sample one, you use reverse transcriptase
to convert all these RNA into DNA
and you add the green fluorophore.
In sample two, you use reverse transcriptase and label all
of those with a red fluorophore, OK?
So sample one is green, sample two is red and then you add both
of those to the DNA microarray.
The ones that are in green are telling you, "Oh, that gene is
up regulated in those types of cells."
The ones that are on red is telling you it's up regulated
in the other types of cells and where red
and green overlap you see yellow, OK?
So, this allows you to compare experiment versus control
and the possibilities are endless.
For example, you can look at cancer versus non-cancer cells,
virus infected versus normal,
G1 phase of the cell cycle versus S-phase.
I'll explain these phases in a moment, young cells versus old,
drug treated versus no drug, et cetera.
And so in the end, you get these massive arrays
where you get a huge amount of data.
Each of these red spots
that could tell you, "Oh, that's a gene.
That's up regulated," and say,
"Cancer cells are virus infected cells."
And then the yellow ones,
those are ones you don't have to worry about.
The green ones though, right, because that's the same
in both types of cells.
The green ones however are ones that are up regulated in the--
let's say, the non-virus cells, OK down regulated
in the case of the cancer cells.
So you can see in one very simple experiment relatively
simple, little complicated, you get out enormous amount
of information about the transcription activity
of an entire cell.
Again, this is all set in place by DNA synthesis,
chemical DNA synthesis.
OK, so here's an example of this, a specific example.
The example I'm going to use is the small molecule FK-506 also
called tacrolimus.
This is a-- immunosuppressant that was discovered
by the chemical--
the pharmaceutical company Fujisawa hence the name FK has
an immunosuppressants.
It is given to patients who had an organ transplanted, OK?
So, this was kicked off sort of a revolution in the area
of liver transplantation for example
when it first became available in the 80s--
late 80s and early 90s.
OK, so if you give this drug to your patients
who have just had the liver transplant,
they will not reject the new transplant of liver, OK,
because their immune system is suppressed.
You can kind of see the problem with that approach.
All right.
I mean the immune system is suppressed that means
that if they get it cold,
they're going to be on big trouble.
Setting that aside, OK, there's other things that you can do.
Let's try to look at what pathways are changed
when we feed cells this compound.
In doing so, we could start to identify the pathways associated
with the immuno response.
And so here's a classic experiment done
by the company called Rosetta Inpharmatics now Merck
pharmaceuticals and in this experiment they have two kinds
of cells.
One kind of cells are green.
They were treated with the green fluorophore
so the transcripts are treated with the green fluorophore
and in the red-- so these have no drug added to them
and on red, those transcripts were treated
with the compound I showed
on the previous slide called FK-506.
In yellow, there's a whole bunch of different compounds.
Check this out.
In green over here, this is a-- this is a protein--
this is gene that encodes a protein that must be turned off
when the compound is added, OK?
Notice that it forms a bright green spot.
Over here, here's one that gets turned on.
It forms a red spot.
The yellow ones, the orange ones,
let's not worry about that so much.
OK. But you can imagine doing all kinds
of analysis of the stuff.
The bioinformatics side of these things, the computation
to analyze the stuff, fascinating, OK,
and a really exciting area of computer science research.
OK, does this make sense?
OK, so one experiment, you get the whole pathway that's being
targeted by this drug.
OK and I'm not telling you very about the pathway now.
Maybe we'll talk about it later.
Yeah. Question at the back.
[ Inaudible Question ]
OK, yeah. So, in practice you have a laser that scans
across the surface of this microarray
and then you have a CCD camera
that captures the intensity of each spot.
OK, I'm hoping this is blowing your mind
because it certainly blows mind.
OK, so now, I wanted to change gears a little bit and talk
to you about how to analyze DNA-- sequences of DNA.
Before I do that, I'm looking at the time here.
I'm going to run all the way up to the 10 before the hour.
But I just want to tell you I have some good news for you,
a little weekend treat.
Thanks for bearing with me of the quiz.
The midterm will only cover through chapter three.
There'll be no chapter four in the midterm, OK?
So when we come back on Tuesday, we'll be talking more about--
don't get ready to go.
I'm not going to stop now but I just want to let you know,
we'll be talking more about DNA and then we'll go into RNA.
But the midterm next Thursday, a week from today, will only cover
through chapter three, OK?
All right, let's get back to our discussion.
I want to switch gears very slightly.
Earlier I alluded to agarose which is used
in those Petri dish plates that I showed you earlier.
Agarose has the structure down here.
It's isolated from seaweed, and it is a polymer
that is tightly crosslet [phonetic] to form a notch, OK.
You can actually form little bricks form of the stuff
and then you can apply the DNA to one end of the agarose gel.
So here's your little brick called an agarose gel
and you add your DNA to one end of this gel
and then you use electrophoresis to push the DNA
through the polymer, OK.
We recall that DNA as negatively charged so it will be attracted
to the positively charged terminal
to possibly charge electrode, the cathode at one end of the--
of your electrophoresis apparatus.
OK, so again, you have this wires coming out.
They're going back to some source of electricity,
some power supply and that's pushing the DNA through the gel.
The DNA will get separated out then
on the basis of its size, OK?
So, bigger DNA is going to get caught
up in this complicated network
over here whereas the little pieces of DNA are going
to find it easier to flow through these little pores.
OK. So in practice, what this looks like is this.
I think I've already shown you one of these agarose gels.
This is the top of the gel where the big pieces are.
Here's the bottom of the gel where the little pieces are.
Again, the big pieces have not migrated as far
because they got stuck in the inner stitches of the DNA.
Frequently, we add what's called a DNA ladder to one lane
of the gel and that provides basically a ruler
that tells us what sizes of DNA we're looking at.
How is this visualized?
Why are these DNA pieces in this color over here lit up?
What do we add to the gel?
>> Ethidium bromide
>> Yes, ethidium bromide.
Thank you.
Yeah. We've added a diethidium bromide that concentrates
in the DNA and is fluorescent.
This works really well.
This tells us a lot about DNA length
and a little bit about its structure.
You can look at for example supercoiling using
this technique.
OK, yeah. Here's the ethidium bromide.
Here it is intercalated into DNA and this
at practice is what it really looks like.
It has this bright purple color.
In addition to separating on gels, we very commonly separate
out DNA using capillary electrophoresis.
And this is a much more effective way of separating
out DNA that it differs by a single base in size.
So you can take a large number of sequences of DNA
and then separate them out such that if you have, you know,
100 meers [phonetic], 99 meers, 98 meers, 97 meers, 96,
et cetera all neatly separated
out using this technique called capillary electrophoresis.
It's the same electrophoresis technique
with a different mobility layer-- different mobility phase
but it's basically using electrophoresis again
but in a capillary.
OK. Here's why this is important.
You can use this gel based separation
as a way of sequencing DNA.
If you had some way of breaking it up into little pieces
where each piece differs by one base pair.
In practice, what we do is--
and I will only tell you about this one over here.
OK, this is the old fashion way to do this in the--
using this actually we use a acrylamide gels.
This is back when I was a post doc.
We no longer do this.
No one in lab does it this way.
We all do it this way.
Here's the way this works.
OK, what we do is we add a very low concentration
of dideoxy terminators.
This is exactly what a-- was invented by Gertrude Elion
on the Gertrude Elion slide that I showed you earlier.
This is missing, the 3' prime hydroxyl.
It has a hydrogen in place over here
and these 3' prime terminators missing this hydroxyl shutdown
DNA polymerase synthesis.
When they do, they also carry along a fluorophore
that has a specific wavelength associated with it, OK?
So you add a one percent concentration
of the dideoxy C inhibitor that has a green flurophore.
You add one percent that has G and has a red fluorphore.
You add one percent that has T and has a purple fluorophore
and you see where this is going.
So you have four dideoxy terminators.
Each one with its own fluorophore
and you set this fluorophores up so there's no overlap
of the wavelengths or a little overlap as you can get.
In the end, you separate out the sequences using capillary
electrophoresis and what you can do is actually read
out based upon the read, green or blue status of each
of those dice that you have a sequence
that says GAT, CTT, GTT, et cetera.
In our practice, we actually, you know, simply take the data,
feed it into a program and the computer gives us the sequence
at the end.
OK, so this stuff is massively automated.
OK, in fact, we're at the point where our lab simply sends
out the sequences and there's another lab.
It used to be on campus but now it's actually-- where is it?
>> I think its San Diego.
>> It's here?
>> San Diego.
>> San Diego.
OK. Yeah. So it's in San Diego that does all the sequencing
for us and it cost only a few dollars per sequence.
OK. And that's-- that price has dropped enormously.
OK, any questions about anything we've seen today?
Yeah, Anthony?
>> Well, I don't know if you said but I'm a little curious
about donor [inaudible] stuff there where you--
>> Oh, yeah, yeah, yeah.
Let's put that off.
>> OK.
>> OK. Yeah.
Fluorescents [phonetic] technology is interesting.
All right, last thing, you can use this DNA technology
for all kinds of things.
It's used very extensively.
You can even use it to program changes in organisms
like drosophila and you can use this to test hypothesis.
Little hard to tell but you see the extra eyeballs
that are growing out of this organism.
Eyeball at the stuck, eyeball over here, yeah.
So you could actually program-- you can insert sequences of DNA
into these organisms and [inaudible] them to get turned
on at specific times and use this some test whether
or not we understand what specific genes do.
And this is actually as fascinating story
that actually deals with a heat shock protein.
OK, there's a couple of ways of modifying DNA in organisms.
One way is to do it randomly using compounds
like this one whose mechanism we'll talk more
about on Tuesday.
So let's stop here.
When we come back next time,
we'll be talking more about this. ------------------------------f77944255c8c--